{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T04:57:12Z","timestamp":1781326632459,"version":"3.54.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"13","license":[{"start":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T00:00:00Z","timestamp":1777248000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T00:00:00Z","timestamp":1777248000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Anal Bioanal Chem"],"published-print":{"date-parts":[[2026,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Biopharmaceuticals, such as monoclonal antibodies (mAb), are complex molecules that require thorough analysis due to post-translational modifications, including charge variants and glycoform patterns. When analyzing intact mAbs, single liquid chromatography (LC) mass spectrometry (MS) methods often lack the resolution to distinguish this heterogeneity because they offer limited separation in both chromatographic and mass dimensions. Consequently, these methods struggle to detect low-abundance species, highlighting the importance of 2DLC-MS workflows. Here, we demonstrate the potential of the offline ion exchange chromatography (IEC)\u2013hydrophilic interaction chromatography (HILIC)\u2013MS method to effectively separate charge and glycoform variants of complex mAbs. Cetuximab served as the model antibody due to its multiple charge variants (arising from sialylation and C-terminal lysine clipping) and four glycosylation sites (in both Fab and Fc regions). Charge variants were first separated using non-volatile IEC and collected as individual fractions. These fractions were then analyzed using a low-flow HILIC-MS setup to increase sensitivity for low-abundance species. A RPLC trap column\u00a0was used to  desalt and reduce the volume transferred to\u00a0the HILIC\u00a0separation. The IEC-HILIC results showed that both Fc- and Fab-associated glycoforms of cetuximab were resolved to a level not achievable with HILIC-MS alone, allowing deeper insights into charge heterogeneity and glycosylation. In addition to resolving combined Fab\/Fc glycoforms, the method also distinguished Fc-only glycoforms from the main isoform. This orthogonal IEC-HILIC method provides additional insights into charge and glycosylation heterogeneity, enabling a more comprehensive analysis of cetuximab. It provides an effective approach for detailed characterization of charge variations and glycoform diversity in next-generation protein therapeutics.<\/jats:p>\n                  <jats:p>\n                    <jats:bold>Graphical abstract<\/jats:bold>\n                  <\/jats:p>\n                  <jats:p>Orthogonal separation of IEC (charge variants) with offline HILIC-MS (glycosylation and characterization of proteoforms)<\/jats:p>","DOI":"10.1007\/s00216-026-06519-w","type":"journal-article","created":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T10:37:25Z","timestamp":1777286245000},"page":"4015-4023","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Resolving charge and glycosylation variants of cetuximab combining offline ion-exchange and hydrophilic interaction chromatography\u2013HRMS"],"prefix":"10.1007","volume":"418","author":[{"given":"Annika A. M.","family":"van der Zon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea F. G.","family":"Gargano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,27]]},"reference":[{"key":"6519_CR1","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1038\/s41587-022-01582-x","volume":"40","author":"G Walsh","year":"2022","unstructured":"Walsh G, Walsh E. Biopharmaceutical benchmarks 2022. Nat Biotechnol. 2022;40:1722\u201360. https:\/\/doi.org\/10.1038\/s41587-022-01582-x.","journal-title":"Nat Biotechnol"},{"key":"6519_CR2","doi-asserted-by":"publisher","DOI":"10.1007\/s00216-025-06036-2","author":"DR Cunha","year":"2025","unstructured":"Cunha DR, Quinaz MB, Segundo MA. Biopharmaceutical analysis \u2014 current analytical challenges, limitations, and perspectives. Anal Bioanal Chem. 2025. https:\/\/doi.org\/10.1007\/s00216-025-06036-2.","journal-title":"Anal Bioanal Chem"},{"key":"6519_CR3","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.biologicals.2016.06.005","volume":"44","author":"N Alt","year":"2016","unstructured":"Alt N, Zhang TY, Motchnik P, Taticek R, Quarmby V, Schlothauer T, et al. Determination of critical quality attributes for monoclonal antibodies using quality by design principles. Biologicals. 2016;44:291\u2013305. https:\/\/doi.org\/10.1016\/j.biologicals.2016.06.005.","journal-title":"Biologicals"},{"key":"6519_CR4","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-47693-8","volume":"15","author":"LF Schachner","year":"2024","unstructured":"Schachner LF, Mullen C, Phung W, Hinkle JD, Beardsley MI, Bentley T, et al. Exposing the molecular heterogeneity of glycosylated biotherapeutics. Nat Commun. 2024;15:3259. https:\/\/doi.org\/10.1038\/s41467-024-47693-8.","journal-title":"Nat Commun"},{"key":"6519_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcpro.2023.100622","volume":"22","author":"F Di Marco","year":"2023","unstructured":"Di Marco F, Bl\u00f6chl C, Esser-Skala W, Sch\u00e4pert\u00f6ns V, Zhang T, Wuhrer M, et al. Glycoproteomics of a Single Protein: Revealing Tens of Thousands of Myozyme Glycoforms by Hybrid HPLC-MS Approaches. Mol Cell Proteomics. 2023;22:100622. https:\/\/doi.org\/10.1016\/j.mcpro.2023.100622.","journal-title":"Mol Cell Proteomics"},{"key":"6519_CR6","doi-asserted-by":"publisher","DOI":"10.1080\/19420862.2025.2537116","author":"J Schairer","year":"2025","unstructured":"Schairer J, H\u00f6chsmann A, Bauer B, H\u00f6fer V, R\u00f6mer J, Neus\u00fc\u00df C. Ion-exchange chromatography, capillary isoelectric focusing, and capillary zone electrophoresis coupled to mass spectrometry for charge variant analysis of monoclonal antibodies. MAbs. 2025. https:\/\/doi.org\/10.1080\/19420862.2025.2537116.","journal-title":"MAbs"},{"key":"6519_CR7","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.jpba.2015.02.037","volume":"113","author":"S Fekete","year":"2015","unstructured":"Fekete S, Beck A, Veuthey J-L, Guillarme D. Ion-exchange chromatography for the characterization of biopharmaceuticals. J Pharm Biomed Anal. 2015;113:43\u201355. https:\/\/doi.org\/10.1016\/j.jpba.2015.02.037.","journal-title":"J Pharm Biomed Anal"},{"key":"6519_CR8","doi-asserted-by":"publisher","DOI":"10.1002\/JSSC.70268","volume":"48","author":"Z Zhai","year":"2025","unstructured":"Zhai Z, Holmark T, Jasperse L, Gargano AFG. Developments in ion exchange chromatography-mass spectrometry for the characterization of intact proteins and proteoforms. J Sep Sci. 2025;48:e70268. https:\/\/doi.org\/10.1002\/JSSC.70268.","journal-title":"J Sep Sci"},{"key":"6519_CR9","doi-asserted-by":"publisher","first-page":"4669","DOI":"10.1021\/ACS.ANALCHEM.7B05241\/ASSET\/IMAGES\/LARGE\/AC-2017-05241F_0006.JPEG","volume":"90","author":"F F\u00fcssl","year":"2018","unstructured":"F\u00fcssl F, Cook K, Scheffler K, Farrell A, Mittermayr S, Bones J. Charge variant analysis of monoclonal antibodies using direct coupled pH gradient cation exchange chromatography to high-resolution native mass spectrometry. Anal Chem. 2018;90:4669\u201376. https:\/\/doi.org\/10.1021\/ACS.ANALCHEM.7B05241\/ASSET\/IMAGES\/LARGE\/AC-2017-05241F_0006.JPEG.","journal-title":"Anal Chem"},{"key":"6519_CR10","doi-asserted-by":"publisher","first-page":"5431","DOI":"10.1021\/ACS.ANALCHEM.0C00185\/ASSET\/IMAGES\/LARGE\/AC0C00185_0004.JPEG","volume":"92","author":"F Fussl","year":"2020","unstructured":"Fussl F, Trappe A, Carillo S, Jakes C, Bones J. Comparative elucidation of cetuximab heterogeneity on the intact protein level by cation exchange chromatography and capillary electrophoresis coupled to mass spectrometry. Anal Chem. 2020;92:5431\u20138. https:\/\/doi.org\/10.1021\/ACS.ANALCHEM.0C00185\/ASSET\/IMAGES\/LARGE\/AC0C00185_0004.JPEG.","journal-title":"Anal Chem"},{"key":"6519_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchromb.2022.123186","volume":"1194","author":"A Trappe","year":"2022","unstructured":"Trappe A, F\u00fcssl F, Mill\u00e1n-Mart\u00edn S, Ronan R, Zaborowska I, Bones J. Correlative N-glycan and charge variant analysis of cetuximab expressed in murine, Chinese hamster and human expression systems. J Chromatogr B Analyt Technol Biomed Life Sci. 2022;1194:123186. https:\/\/doi.org\/10.1016\/j.jchromb.2022.123186.","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"6519_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.trac.2023.117166","volume":"166","author":"RS van den Hurk","year":"2023","unstructured":"van den Hurk RS, Pursch M, Stoll DR, Pirok BWJ. Recent trends in two-dimensional liquid chromatography. TrAC Trends Anal Chem. 2023;166:117166. https:\/\/doi.org\/10.1016\/j.trac.2023.117166.","journal-title":"TrAC Trends Anal Chem"},{"key":"6519_CR13","doi-asserted-by":"publisher","first-page":"291","DOI":"10.3390\/ph16020291","volume":"16","author":"HA Alhazmi","year":"2023","unstructured":"Alhazmi HA, Albratty M. Analytical techniques for the characterization and quantification of monoclonal antibodies. Pharmaceuticals. 2023;16:291. https:\/\/doi.org\/10.3390\/ph16020291.","journal-title":"Pharmaceuticals"},{"key":"6519_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/J.CHROMA.2022.463721","volume":"1688","author":"M Passamonti","year":"2023","unstructured":"Passamonti M, Zhai Z, Moreschini M, Wilson JW, Zhou M, Schoenmakers PJ, et al. Influence of ion-pairing reagents on the separation of intact glycoproteins using hydrophilic-interaction liquid chromatography - high-resolution mass spectrometry. J Chromatogr A. 2023;1688:463721. https:\/\/doi.org\/10.1016\/J.CHROMA.2022.463721.","journal-title":"J Chromatogr A"},{"key":"6519_CR15","doi-asserted-by":"publisher","first-page":"5909","DOI":"10.1021\/acs.analchem.2c00139","volume":"94","author":"JW Wilson","year":"2022","unstructured":"Wilson JW, Bilbao A, Wang J, Liao Y-C, Velickovic D, Wojcik R, et al. Online hydrophilic interaction chromatography (HILIC) enhanced top-down mass spectrometry characterization of the SARS-CoV-2 spike receptor-binding domain. Anal Chem. 2022;94:5909\u201317. https:\/\/doi.org\/10.1021\/acs.analchem.2c00139.","journal-title":"Anal Chem"},{"key":"6519_CR16","doi-asserted-by":"publisher","first-page":"4684","DOI":"10.1021\/ACS.JPROTEOME.4C00600","volume":"23","author":"VK James","year":"2024","unstructured":"James VK, van der Zon AAM, Escobar EE, Dunham SD, Gargano AFG, Brodbelt JS. Hydrophilic interaction chromatography coupled to ultraviolet photodissociation affords identification, localization, and relative quantitation of glycans on intact glycoproteins. J Proteome Res. 2024;23:4684\u201393. https:\/\/doi.org\/10.1021\/ACS.JPROTEOME.4C00600.","journal-title":"J Proteome Res"},{"key":"6519_CR17","doi-asserted-by":"publisher","first-page":"2086","DOI":"10.1021\/acs.analchem.6b04726","volume":"89","author":"V D\u2019Atri","year":"2017","unstructured":"D\u2019Atri V, Fekete S, Beck A, Lauber M, Guillarme D. Hydrophilic interaction chromatography hyphenated with mass spectrometry: a powerful analytical tool for the comparison of originator and biosimilar therapeutic monoclonal antibodies at the middle-up level of analysis. Anal Chem. 2017;89:2086\u201392. https:\/\/doi.org\/10.1021\/acs.analchem.6b04726.","journal-title":"Anal Chem"},{"key":"6519_CR18","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.talanta.2018.03.015","volume":"184","author":"E Dom\u00ednguez-Vega","year":"2018","unstructured":"Dom\u00ednguez-Vega E, Tengattini S, Peintner C, van Angeren J, Temporini C, Haselberg R, et al. High-resolution glycoform profiling of intact therapeutic proteins by hydrophilic interaction chromatography-mass spectrometry. Talanta. 2018;184:375\u201381. https:\/\/doi.org\/10.1016\/j.talanta.2018.03.015.","journal-title":"Talanta"},{"key":"6519_CR19","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.aca.2017.05.020","volume":"981","author":"S Tengattini","year":"2017","unstructured":"Tengattini S, Dom\u00ednguez-Vega E, Temporini C, Bavaro T, Rinaldi F, Piubelli L, et al. Hydrophilic interaction liquid chromatography-mass spectrometry as a new tool for the characterization of intact semi-synthetic glycoproteins. Anal Chim Acta. 2017;981:94\u2013105. https:\/\/doi.org\/10.1016\/j.aca.2017.05.020.","journal-title":"Anal Chim Acta"},{"key":"6519_CR20","doi-asserted-by":"publisher","first-page":"6601","DOI":"10.1021\/acs.analchem.8b00382","volume":"90","author":"AFG Gargano","year":"2018","unstructured":"Gargano AFG, Roca LS, Fellers RT, Bocxe M, Dom\u00ednguez-Vega E, Somsen GW. Capillary HILIC-MS: a new tool for sensitive top-down proteomics. Anal Chem. 2018;90:6601\u20139. https:\/\/doi.org\/10.1021\/acs.analchem.8b00382.","journal-title":"Anal Chem"},{"key":"6519_CR21","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics13111744","volume":"13","author":"BL Duivelshof","year":"2021","unstructured":"Duivelshof BL, Denorme S, Sandra K, Liu X, Beck A, Lauber MA, et al. Quantitative N-glycan profiling of therapeutic monoclonal antibodies performed by middle-up level HILIC-HRMS analysis. Pharmaceutics. 2021;13:1744. https:\/\/doi.org\/10.3390\/pharmaceutics13111744.","journal-title":"Pharmaceutics"},{"key":"6519_CR22","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.02049","author":"T S\u00e9nard","year":"2020","unstructured":"S\u00e9nard T, Gargano AFG, Falck D, de Taeye SW, Rispens T, Vidarsson G, et al. MS-based allotype-specific analysis of polyclonal IgG-Fc N-glycosylation. Front Immunol. 2020. https:\/\/doi.org\/10.3389\/fimmu.2020.02049.","journal-title":"Front Immunol"},{"key":"6519_CR23","doi-asserted-by":"publisher","first-page":"13569","DOI":"10.1021\/ACS.ANALCHEM.5C02033\/ASSET\/IMAGES\/LARGE\/AC5C02033_0002.JPEG","volume":"97","author":"AAM van der Zon","year":"2025","unstructured":"van der Zon AAM, Hana L\u00cfN, Husein H, Holmark T, Zhai Z, Gargano AFG. Hydrophilic interaction chromatography HRMS with acrylamide monolithic columns: a novel approach for intact antibody glycoform characterization. Anal Chem. 2025;97:13569\u201376. https:\/\/doi.org\/10.1021\/ACS.ANALCHEM.5C02033\/ASSET\/IMAGES\/LARGE\/AC5C02033_0002.JPEG.","journal-title":"Anal Chem"},{"key":"6519_CR24","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1002\/jssc.201700863","volume":"41","author":"BWJ Pirok","year":"2018","unstructured":"Pirok BWJ, Gargano AFG, Schoenmakers PJ. Optimizing separations in online comprehensive two-dimensional liquid chromatography. J Sep Sci. 2018;41:68\u201398. https:\/\/doi.org\/10.1002\/jssc.201700863.","journal-title":"J Sep Sci"},{"key":"6519_CR25","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.jpba.2014.08.035","volume":"102","author":"S Fekete","year":"2015","unstructured":"Fekete S, Beck A, Fekete J, Guillarme D. Method development for the separation of monoclonal antibody charge variants in cation exchange chromatography, Part I: salt gradient approach. J Pharm Biomed Anal. 2015;102:33\u201344. https:\/\/doi.org\/10.1016\/j.jpba.2014.08.035.","journal-title":"J Pharm Biomed Anal"},{"key":"6519_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.chroma.2023.464498","volume":"1713","author":"R P\u00e9rez-Robles","year":"2024","unstructured":"P\u00e9rez-Robles R, Fekete S, Korm\u00e1ny R, Navas N, Guillarme D. Improved sample introduction approach in hydrophilic interaction liquid chromatography to avoid breakthrough of proteins. J Chromatogr A. 2024;1713:464498. https:\/\/doi.org\/10.1016\/j.chroma.2023.464498.","journal-title":"J Chromatogr A"},{"key":"6519_CR27","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1021\/acs.jafc.3c07496","volume":"72","author":"M Liu","year":"2024","unstructured":"Liu M, Zhao Y, Li X, Zhang T, Xu X, Jiang M, et al. Two multidimensional chromatography\/high-resolution mass spectrometry approaches enabling the in-depth metabolite characterization simultaneously from three Glycyrrhiza species: method development, comparison, and integration. J Agric Food Chem. 2024;72:1339\u201353. https:\/\/doi.org\/10.1021\/acs.jafc.3c07496.","journal-title":"J Agric Food Chem"},{"key":"6519_CR28","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.chroma.2007.09.028","volume":"1189","author":"K Deguchi","year":"2008","unstructured":"Deguchi K, Keira T, Yamada K, Ito H, Takegawa Y, Nakagawa H, et al. Two-dimensional hydrophilic interaction chromatography coupling anion-exchange and hydrophilic interaction columns for separation of 2-pyridylamino derivatives of neutral and sialylated N-glycans. J Chromatogr A. 2008;1189:169\u201374. https:\/\/doi.org\/10.1016\/j.chroma.2007.09.028.","journal-title":"J Chromatogr A"},{"key":"6519_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.chroma.2021.462237","volume":"1649","author":"K Feng","year":"2021","unstructured":"Feng K, Wang S, Han L, Qian Y, Li H, Li X, et al. Configuration of the ion exchange chromatography, hydrophilic interaction chromatography, and reversed-phase chromatography as off-line three-dimensional chromatography coupled with high-resolution quadrupole-Orbitrap mass spectrometry for the multicomponent characterization of Uncaria sessilifructus. J Chromatogr A. 2021;1649:462237. https:\/\/doi.org\/10.1016\/j.chroma.2021.462237.","journal-title":"J Chromatogr A"},{"key":"6519_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchromb.2022.123186","volume":"1194","author":"A Trappe","year":"2022","unstructured":"Trappe A, F\u00fcssl F, Mill\u00e1n-Mart\u00edn S, Ronan R, Zaborowska I, Bones J. Correlative N-glycan and charge variant analysis of cetuximab expressed in murine, chinese hamster and human expression systems. J Chromatogr B. 2022;1194:123186. https:\/\/doi.org\/10.1016\/j.jchromb.2022.123186.","journal-title":"J Chromatogr B"},{"key":"6519_CR31","doi-asserted-by":"publisher","first-page":"13569","DOI":"10.1021\/acs.analchem.5c02033","volume":"97","author":"AAM van der Zon","year":"2025","unstructured":"van der Zon AAM, Hana LN, Husein H, Holmark T, Zhai Z, Gargano AFG. Hydrophilic interaction chromatography HRMS with acrylamide monolithic columns: a novel approach for intact antibody glycoform characterization. Anal Chem. 2025;97:13569\u201376. https:\/\/doi.org\/10.1021\/acs.analchem.5c02033.","journal-title":"Anal Chem"},{"key":"6519_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpba.2019.113035","volume":"180","author":"C V\u00e1radi","year":"2020","unstructured":"V\u00e1radi C, Jakes C, Bones J. Analysis of cetuximab N-glycosylation using multiple fractionation methods and capillary electrophoresis mass spectrometry. J Pharm Biomed Anal. 2020;180:113035. https:\/\/doi.org\/10.1016\/j.jpba.2019.113035.","journal-title":"J Pharm Biomed Anal"},{"key":"6519_CR33","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0170013","volume":"12","author":"S Liu","year":"2017","unstructured":"Liu S, Gao W, Wang Y, He Z, Feng X, Liu B-F, et al. Comprehensive N-glycan profiling of cetuximab biosimilar candidate by NP-HPLC and MALDI-MS. PLoS ONE. 2017;12:e0170013. https:\/\/doi.org\/10.1371\/journal.pone.0170013.","journal-title":"PLoS ONE"},{"key":"6519_CR34","doi-asserted-by":"publisher","first-page":"5431","DOI":"10.1021\/acs.analchem.0c00185","volume":"92","author":"F F\u00fcssl","year":"2020","unstructured":"F\u00fcssl F, Trappe A, Carillo S, Jakes C, Bones J. Comparative elucidation of cetuximab heterogeneity on the intact protein level by cation exchange chromatography and capillary electrophoresis coupled to mass spectrometry. Anal Chem. 2020;92:5431\u20138. https:\/\/doi.org\/10.1021\/acs.analchem.0c00185.","journal-title":"Anal Chem"},{"key":"6519_CR35","doi-asserted-by":"publisher","first-page":"4370","DOI":"10.1021\/acs.analchem.5b00140","volume":"87","author":"MT Marty","year":"2015","unstructured":"Marty MT, Baldwin AJ, Marklund EG, Hochberg GKA, Benesch JLP, Robinson CV. Bayesian deconvolution of mass and ion mobility spectra: from binary interactions to polydisperse ensembles. Anal Chem. 2015;87:4370\u20136. https:\/\/doi.org\/10.1021\/acs.analchem.5b00140.","journal-title":"Anal Chem"},{"key":"6519_CR36","doi-asserted-by":"publisher","first-page":"699","DOI":"10.4161\/mabs.25423","volume":"5","author":"D Ayoub","year":"2013","unstructured":"Ayoub D, Jabs W, Resemann A, Evers W, Evans C, Main L, et al. Correct primary structure assessment and extensive glyco-profiling of cetuximab by a combination of intact, middle-up, middle-down and bottom-up ESI and MALDI mass spectrometry techniques. MAbs. 2013;5:699\u2013710. https:\/\/doi.org\/10.4161\/mabs.25423.","journal-title":"MAbs"},{"key":"6519_CR37","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1093\/glycob\/cwz045","volume":"29","author":"S Neelamegham","year":"2019","unstructured":"Neelamegham S, Aoki-Kinoshita K, Bolton E, Frank M, Lisacek F, L\u00fctteke T, et al. Updates to the symbol nomenclature for glycans guidelines. Glycobiology. 2019;29:620\u20134. https:\/\/doi.org\/10.1093\/glycob\/cwz045.","journal-title":"Glycobiology"},{"key":"6519_CR38","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.jchromb.2017.09.033","volume":"1065\u20131066","author":"A Goyon","year":"2017","unstructured":"Goyon A, Excoffier M, Janin-Bussat M-C, Bobaly B, Fekete S, Guillarme D, et al. Determination of isoelectric points and relative charge variants of 23 therapeutic monoclonal antibodies. J Chromatogr B. 2017;1065\u20131066:119\u201328. https:\/\/doi.org\/10.1016\/j.jchromb.2017.09.033.","journal-title":"J Chromatogr B"},{"key":"6519_CR39","doi-asserted-by":"publisher","DOI":"10.3390\/ph16020291","volume":"16","author":"HA Alhazmi","year":"2023","unstructured":"Alhazmi HA, Albratty M. Analytical techniques for the characterization and quantification of monoclonal antibodies. Pharmaceuticals. 2023;16:291. https:\/\/doi.org\/10.3390\/ph16020291.","journal-title":"Pharmaceuticals"},{"key":"6519_CR40","doi-asserted-by":"publisher","first-page":"22706","DOI":"10.1039\/c3ra42969e","volume":"3","author":"G Palmisano","year":"2013","unstructured":"Palmisano G, Larsen MR, Packer NH, Thaysen-Andersen M. Structural analysis of glycoprotein sialylation \u2013 part II: lc-ms based detection. RSC Adv. 2013;3:22706. https:\/\/doi.org\/10.1039\/c3ra42969e.","journal-title":"RSC Adv"},{"key":"6519_CR41","doi-asserted-by":"publisher","unstructured":"Spanov B, Govorukhina N, van de NC, Bischoff R. Analytical tools for the characterization of deamidation in monoclonal antibodies. J Chromatogr Open. 2022;2:100025. https:\/\/doi.org\/10.1016\/j.jcoa.2021.100025.","DOI":"10.1016\/j.jcoa.2021.100025"},{"key":"6519_CR42","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1002\/jps.24675","volume":"105","author":"A Masato","year":"2016","unstructured":"Masato A, Kiichi F, Uchiyama S. Suppression of methionine oxidation of a pharmaceutical antibody stored in a polymer-based syringe. J Pharm Sci. 2016;105:623\u20139. https:\/\/doi.org\/10.1002\/jps.24675.","journal-title":"J Pharm Sci"}],"container-title":["Analytical and Bioanalytical Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00216-026-06519-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00216-026-06519-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00216-026-06519-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T04:28:31Z","timestamp":1781324911000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00216-026-06519-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,27]]},"references-count":42,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["6519"],"URL":"https:\/\/doi.org\/10.1007\/s00216-026-06519-w","relation":{"has-preprint":[{"id-type":"doi","id":"10.26434\/chemrxiv.15000403\/v1","asserted-by":"object"}]},"ISSN":["1618-2642","1618-2650"],"issn-type":[{"value":"1618-2642","type":"print"},{"value":"1618-2650","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,27]]},"assertion":[{"value":"23 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}